Category
Amidotrizoic acid
CAS Number
NA
Molecular Formula
C₁₃H₁₁I₃N₂O₅
Molecular Weight
656 g/mol
Synonym

3-(Acetylamino)-5-(diacetylamino)-2,4,6-triiodobenzoic acid (as per EP);3-(Acetylamino)-5-(diacetylamino)-2,4,6-triiodobenzoic Acid ; 3-Acetamido-5-(N-acetylacetamido)-2,4,6-triiodobenzoic Acid;

Keywords
Fine Chemicals
Aromatics
Pharmaceutical Standards
Metabolites.
Impurities
Intermediates
High-Quality Pharmaceutical Reference Standards
Impurities Manufacturer in India
Impurities manufacturer and Suppliers in Hyderabad india
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Amidotrizoic Acid EP Impurity E (molecular formula C₁₃H₁₁I₃N₂O₅; molecular weight 656) is a high-quality Amidotrizoic acid pharmaceutical impurity and analytical reference standard used for impurity profiling, HPLC analysis, related-substance testing, pharmaceutical research, quality control, analytical method development, and validation. Manasa Life Sciences is an India-based manufacturer and supplier of pharmaceutical analytical impurities, offering comprehensive product documentation and analytical data to support research and quality-control requirements. Documentation and analytical practices may be aligned, where applicable, with EP, USP, EMA, and ICH regulatory guidance, including ICH requirements concerning impurities, analytical validation, specifications, and pharmaceutical quality systems. Depending on the individual product and batch, the documentation package may include COA, potency/assay, analytical chromatograms, characterization data, specifications, and applicable GLP/GDP documentation. EMA guidance specifically recognizes the importance of analytical procedures, validation, batch analysis, impurity specifications, and reference standards/materials in pharmaceutical quality documentation